{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T01:46:45Z","timestamp":1712108805496},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,2]]},"DOI":"10.7759\/cureus.57469","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T19:02:23Z","timestamp":1712084543000},"source":"Crossref","is-referenced-by-count":0,"title":["Carbohydrate Antigen (CA 19-9) Surge: Unraveling the Enigma of Elevated Levels in the Setting of Benign Etiologies"],"prefix":"10.7759","author":[{"given":"Nida","family":"Ansari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sacide S","family":"Ozgur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damian","family":"Besada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noor","family":"Bittar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Melki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanthi","family":"Badipatla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derick","family":"Christian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yana","family":"Cavanagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4240\/wjgs.v12.i12.468","article-title":"Carbohydrate antigen 19-9 - tumor marker: Past, present, and future","volume":"12","author":"Lee T","year":"2020","unstructured":"Lee T, Teng TZ, Shelat VG. Carbohydrate antigen 19-9 - tumor marker: Past, present, and future. World J Gastrointest Surg. 2020, 12:468-90. 10.4240\/wjgs.v12.i12.468","journal-title":"World J Gastrointest Surg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.15684","article-title":"Mucins in pancreatic cancer: A well-established but promising family for diagnosis, prognosis and therapy","volume":"24","author":"Wang S","year":"2020","unstructured":"Wang S, You L, Dai M, Zhao Y. Mucins in pancreatic cancer: A well-established but promising family for diagnosis, prognosis and therapy. J Cell Mol Med. 2020, 24:10279-89. 10.1111\/jcmm.15684","journal-title":"J Cell Mol Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126567","article-title":"MUC1: structure, function, and clinic application in epithelial cancers","volume":"22","author":"Chen W","year":"2021","unstructured":"Chen W, Zhang Z, Zhang S, Zhu P, Ko JK, Yung KK. MUC1: structure, function, and clinic application in epithelial cancers. Int J Mol Sci. 2021, 22:10.3390\/ijms22126567","journal-title":"Int J Mol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-017-7215-0_15","article-title":"CA 19-9: Biochemical and clinical aspects","volume":"867","author":"Scar\u00e0 S","year":"2015","unstructured":"Scar\u00e0 S, Bottoni P, Scatena R. CA 19-9: Biochemical and clinical aspects. Adv Exp Med Biol. 2015, 867:247-60. 10.1007\/978-94-017-7215-0_15","journal-title":"Adv Exp Med Biol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2018.09.004","article-title":"Dilemma of elevated CA 19-9 in biliary pathology","volume":"18","author":"Tsen A","year":"2018","unstructured":"Tsen A, Barbara M, Rosenkranz L. Dilemma of elevated CA 19-9 in biliary pathology. Pancreatology. 2018, 18:862-7. 10.1016\/j.pan.2018.09.004","journal-title":"Pancreatology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2174\/1566524011313030003","article-title":"The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates","volume":"13","author":"Poruk KE","year":"2013","unstructured":"Poruk KE, Gay DZ, Brown K, et al.. The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates. Curr Mol Med. 2013, 13:340-51. 10.2174\/1566524011313030003","journal-title":"Curr Mol Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2006.10.004","article-title":"Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer","volume":"33","author":"Goonetilleke KS","year":"2007","unstructured":"Goonetilleke KS, Siriwardena AK. Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol. 2007, 33:266-70. 10.1016\/j.ejso.2006.10.004","journal-title":"Eur J Surg Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4076\/1757-1626-2-6662","article-title":"Highly elevated serum levels of CA 19-9 in choledocholithiasis: a case report","volume":"2","author":"Marcouizos G","year":"2009","unstructured":"Marcouizos G, Ignatiadou E, Papanikolaou GE, Ziogas D, Fatouros M. Highly elevated serum levels of CA 19-9 in choledocholithiasis: a case report. Cases J. 2009, 2:6662. 10.4076\/1757-1626-2-6662","journal-title":"Cases J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.32447","article-title":"A case of choledocholithiasis and obstructive jaundice with a very high serum carbohydrate antigen 19-9 (CA 19-9) level: a case report and review of literature","volume":"14","author":"Ghallab M","year":"2022","unstructured":"Ghallab M, Abosheaishaa H, Gupta I, Abdelmoteleb S, Stern R. A case of choledocholithiasis and obstructive jaundice with a very high serum carbohydrate antigen 19-9 (CA 19-9) level: a case report and review of literature. Cureus. 2022, 14:e32447. 10.7759\/cureus.32447","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1159\/000448068","article-title":"Acute cholecystitis with significantly elevated levels of serum carbohydrate antigen 19-9","volume":"10","author":"Akimoto S","year":"2016","unstructured":"Akimoto S, Banshodani M, Nishihara M, et al.. Acute cholecystitis with significantly elevated levels of serum carbohydrate antigen 19-9. Case Rep Gastroenterol. 2016, 10:410-6. 10.1159\/000448068","journal-title":"Case Rep Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/216811-carbohydrate-antigen-ca-19-9-surge-unraveling-the-enigma-of-elevated-levels-in-the-setting-of-benign-etiologies","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T19:02:26Z","timestamp":1712084546000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/216811-carbohydrate-antigen-ca-19-9-surge-unraveling-the-enigma-of-elevated-levels-in-the-setting-of-benign-etiologies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,2]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.57469","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,2]]}}}